Corilagin and 1,3,6-Tri- O -galloy-β- d -glucose: potential inhibitors of SARS-CoV-2 variants
2021; Royal Society of Chemistry; Volume: 23; Issue: 27 Linguagem: Inglês
10.1039/d1cp01790j
ISSN1463-9084
AutoresVincent Binette, Sébastien Côté, Mohamed Haddad, Phuong Nguyen, Sébastien Bélanger, Steve Bourgault, Charles Ramassamy, Roger Gaudreault, Normand Mousseau,
Tópico(s)Berberine and alkaloids research
ResumoThe COVID-19 disease caused by the virus SARS-CoV-2, first detected in December 2019, is still emerging through virus mutations.
Referência(s)